Health breakthroughs and money matters, in plain words

Home » Wendy Beauchesne Leads Transformational Alberta Cancer Trial Investment

Alberta Cancer Foundation Commits $35 Million to Cancer Clinical Trials

By

–

Wendy Beauchesne Leads Transformational Alberta Cancer Trial Investment

On any given day, Albertans can enter more than 200 active cancer clinical trials. The Alberta Cancer Foundation announced on July 6, 2026, that it will put $35 million into keeping that number up and pushing it higher.

The money runs over five years. The Foundation says it is one of the largest investments in clinical trials over a five-year stretch in its history. Part of it will back new treatments, and part will cover the unglamorous daily running of trials, the work that makes existing therapies safer, faster and more effective for patients.

“Clinical trials are the backbone of progress in cancer care and ultimately turn medical breakthroughs today into standard of care for future generations,” said Wendy Beauchesne, the Foundation’s CEO. She said the Foundation and its donors want to speed the path from discovery to patients, “so promising new treatments reach Alberta patients faster.”

Where the money goes

The funding will pay for operations and bigger facilities at the province’s main research hubs. In Calgary, those are the Riddell Centre for Cancer Immunotherapy and the Owerko Family Centre for Clinical Trials. In Edmonton, it is the Clinical Trials Unit at the Cross Cancer Institute, where teams are working to speed up CAR T-cell therapy and other new immunotherapies.

Lethbridge gets a trial of its own. The investment will help launch a study there that uses advanced MRI imaging to test whether doctors can safely cut the number of radiation sessions prostate cancer patients need.

For a man facing weeks of daily treatment, fewer sessions would mean fewer trips to the clinic. That is the question the trial is built to answer.

Tied to the provincial plan

The announcement builds on the Government of Alberta’s new 10-Year Cancer Care Strategy, announced in June. It aims to improve outcomes and patient experiences, advance research and strengthen cancer care.

Brenda Hubley, managing director of Cancer Care Alberta, said the investment “directly accelerates Alberta’s Strategic Plan for Cancer to 2036.” More trial capacity, she said, brings “more innovative treatment options to Albertans right now,” and she thanked the donors behind it for patients and families across the province.

The Foundation describes itself as the fundraising engine behind every cancer centre in Alberta.

Sources

Get breaking stories first on our Telegram channel.

More stories by

Most read

Health & Medicine

Personal Finance

Cancer News

Health News